Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Surgeon General
  • Cigna’s ACA Exit
  • Visa Program
  • Medicaid Work Requirements
  • Gavin Newsom

TRENDING TOPICS:

  • Surgeon General
  • Cigna's ACA Exit
  • Visa Program
  • Medicaid Work Requirements
  • Gavin Newsom

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Feb 19 2026

Full Issue

Trump's FDA To Require Only One Study For Drug Approvals, Not Two

In changing the longtime standard, administration officials aim to speed up the approval process. Also in the news: domestic production of glyphosate, fluoride in drinking water, and more.

AP: FDA Drug Approvals: Makary And Prasad Say One Study Will Be Enough

The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous studies to win approval for new drugs, the latest change from Trump administration officials vowing to speed up the availability of certain medical products. Going forward, the FDA’s “default position” will be to require one study for new drugs and other novel health products, FDA Commissioner Dr. Marty Makary and a top deputy, Dr. Vinay Prasad, wrote in a New England Journal of Medicine piece published Wednesday. (Perrone, 2/18)

More pharma news from the Trump administration —

The New York Times: Trump’s Order Aims To Boost Ingredient Used In Roundup 

President Trump issued an executive order late Wednesday aimed at spurring the domestic production of glyphosate, a widely used weedkiller that has figured in health lawsuits. The move immediately set off alarms among supporters of Health Secretary Robert F. Kennedy Jr.’s “Make America Healthy Again” movement, and appeared to put Mr. Kennedy in an awkward position. (Tabuchi and Stolberg, 2/18)

Stat: New FDA Guidance On Antibiotic Use In Food-Producing Animals Stirs Criticism

In a bid to mitigate antibiotic resistance, the Food and Drug Administration has released guidance for drugmakers to define how long medically important antibiotics should be used in food-producing animals. But critics argue the effort fails to consider the impact on human health. (Silverman, 2/18)

North Carolina Health News: Dentists, Oral Health Advocates Urge EPA To Use ‘Gold Standard Science’ In Its Fluoride Review 

When Lee Zeldin, head of the U.S. Environmental Protection Agency, announced almost 10 months ago that the federal regulator would reevaluate research on potential health risks of fluoride in drinking water, he said “sound science” would be used to “advance our mission of protecting human and health and the environment.” (Blythe, 2/19)

On climate, immigration, race, and RFK Jr. —

The Hill: Groups Sue Trump Over Repeal Of Climate Regulations

A coalition of health and environmental organizations sued the Trump administration on Wednesday over its decision to repeal a landmark legal finding that climate change poses a threat to the public. The groups also challenged the administration’s move to eliminate all climate rules for motor vehicles, which were repealed along with the endangerment finding. The filing did not lay out their reasons for the challenge, but in public statements, the groups argued that the move threatens public health and the environment. (Frazin, 2/18)

AP: US Rep. Joaquin Castro Says The US Deported A Baby With Bronchitis

U.S. immigration authorities deported a 2-month-old baby with bronchitis to Mexico along with his family, a U.S. representative from Texas said. The child was so sick he had been unresponsive “in the last several hours” but was discharged from the hospital anyway, U.S. Rep. Joaquin Castro said Tuesday in an X post. Immigration and Customs Enforcement deported the baby along with his 16-month-old sister, his mother and his father, Castro said. The Democratic lawmaker said he confirmed this with the family’s attorney. (McAvoy, 2/19)

The Washington Post: Colleges Quietly Cut Ties With Organizations That Help People Of Color  

The Trump administration’s objection to a program that helps people of color pursue doctorate degrees has prompted colleges to cut ties with a range of organizations associated with racial minority groups, a Post investigation has found. (Wallack, 2/19)

The Baltimore Sun: Robert F. Kennedy Jr. On Faith, Recovery And President Trump

In a wide-ranging interview with The Baltimore Sun, U.S. Secretary of Health and Human Services Robert F. Kennedy Jr. reflected on his Catholic upbringing, his decades in recovery, enduring public criticism — including from his own family — and his working relationship with President Donald Trump. (Williams, 2/18)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, May 1
  • Thursday, April 30
  • Wednesday, April 29
  • Tuesday, April 28
  • Monday, April 27
  • Friday, April 24
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF